Synonym: 2-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-ethyl- 2,4-dihydro-4-(2-phenoxyethyl)-3H-1,2,4-triazol-3-one hydrochloride; BMY-13754; MJ-13754-1; Serzone
CAS Number: 82752-99-6
Empirical Formula (Hill Notation): C25H32ClN5O2 · HCl
Molecular Weight: 506.47
MDL Number: MFCD00935760
Linear Formula: C25H32ClN5O2 · HCl
Product Type: Chemical
This picture is provided solely for illustration purposes, it may have been created or edited with AI. Optical properties of the actual product may deviate. Relevant product information is printed on labeled products and other accompanying or available information material.
This image depicts N5536-50MG.
| assay |
≥98% (HPLC) |
| color |
white |
| form |
solid |
| InChI |
1S/C25H32ClN5O2.ClH/c1-2-24-27-31(25(32)30(24)18-19-33-23-10-4-3-5-11-23)13-7-12-28-14-16-29(17-15-28)22-9-6-8-21(26)20-22;/h3-6,8-11,20H,2,7,12-19H2,1H3;1H |
| InChI key |
DYCKFEBIOUQECE-UHFFFAOYSA-N |
| originator |
Bristol-Myers Squibb |
| Quality Level |
100  |
| SMILES string |
O=C1N(CCCN2CCN(C3=CC=CC(Cl)=C3)CC2)N=C(CC)N1CCOC4=CC=CC=C4.Cl |
| solubility |
DMSO: ≥10 mg/mL |
| |
H2O: insoluble |
| storage condition |
desiccated |
| Biochem/physiol Actions: |
Novel antidepressant; mixed 5-HT2A serotonin receptor antagonist/serotonin uptake inhibitor. |
| Features and Benefits: |
This compound was developed by Bristol-Myers Squibb . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| Packaging: |
10, 50 mg in glass bottle |
| RIDADR |
NONH for all modes of transport |
| WGK Germany |
WGK 3 |
| Flash Point(F) |
Not applicable |
| Flash Point(C) |
Not applicable |
| Purity |
≥98% (HPLC) |
| UNSPSC |
12352200 |